Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.

Journal of clinical gastroenterology - 1 Jan 2000

Strisciuglio Caterina, Bellini Giulia, Miele Erasmo, Martinelli Massimo, Cenni Sabrina, Tortora Chiara, Tolone Carlo, Miraglia Del Giudice Emanuele, Rossi Francesca

Abstract excerpt

GOALS: We conducted a case-control association analysis to establish the role of a common CB2 functional variant, Q63R, in the susceptibility to inflammatory bowel disease (IBD). BACKGROUND: Endocannabinoids may limit intestinal inflammation through cannabinoid receptor 1 and/or 2 (CB1, CB2). STUDY: We genotyped 217 pediatric IBD patients [112 Crohn's disease (CD), 105 ulcerative colitis (UC)] and 600 controls...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Endocannabinoids

Share to Logistic Models

Share to Multivariate Analysis

Share to Receptor, Cannabinoid, CB2

Share to Severity of Illness Index

Source

Identifiers

PMID: 27875353
DOI: 10.1097/MCG.0000000000000755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.PMID 27875353Read ↗

No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.Semantic proximity Read ↗

The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.Semantic proximity Read ↗

The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.Semantic proximity Read ↗

Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.Semantic proximity Read ↗

Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.Semantic proximity Read ↗

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.Semantic proximity Read ↗

Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.Semantic proximity Read ↗

Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.Semantic proximity Read ↗

The role of fatty acid hydrolase gene variants in inflammatory bowel disease.Semantic proximity Read ↗

Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.Semantic proximity Read ↗

Cannabinoids and the gut: new developments and emerging concepts.Semantic proximity Read ↗

Investigation of associations between the pregnane-X receptor gene (NR1I2) and Crohn's disease in Canadian children using a gene-wide haplotype-based approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.